Teva CEO Kare Schultz’s pay fell in 2021
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kare Schultz saw his pay fall to $14.7 million in 2021 from $15.7 million in 2020, the company reported in its expanded 2021 financial statement. $10…